Special Report | Markets in Turmoil: Airlines & Future of Sports
Listen to CNBC's special report on how the novel Coronavirus outbreak is spreading in the United States, and how it's continuing to hit stock markets around the world. Hosted by Simplecast, an AdsWizz...
5 Mai 202045min
Warren Buffett: “Nothing can stop America”
Berkshire Hathaway’s 2020 annual shareholder meeting, the “Woodstock for Capitalists” -- which allows the company’s 40,000+ investors to question the Oracle of Omaha directly -- was hosted virtually f...
4 Mai 202036min
Special Report | Markets in Turmoil: Gilead & COVID-19 Testing
Listen to CNBC's special report on how the novel Coronavirus outbreak is spreading in the United States, and how it's continuing to hit stock markets around the world. Hosted by Simplecast, an AdsWizz...
2 Mai 202045min
Gilead’s Remdesivir, the Drug that Could Treat Covid-19
Gilead CEO Daniel O’Day shares details of Remdesivir’s two positive trials against Covid-19. He explains collaboration among global drugmakers, the process of finding a treatment for coronavirus, and ...
1 Mai 202037min
Special Report | Markets in Turmoil: Healthcare & Reopening
Listen to CNBC's special report on how the novel Coronavirus outbreak is spreading in the United States, and how it's continuing to hit stock markets around the world. Hosted by Simplecast, an AdsWizz...
1 Mai 202044min
Elon Musk off Script; Jobless Claims with U.S. Labor Secretary; Former White House Insider Steve Bannon
Tesla CEO Elon Musk’s expletive-laced rant and subsequent tweet about American shelter-in-place orders has Wall Street and Main Street abuzz. The rolling total of Americans who’ve filed for unemployme...
30 Apr 202028min
Special Report | Markets in Turmoil: Gilead Latest
Listen to CNBC's special report on how the novel Coronavirus outbreak is spreading in the United States, and how it's continuing to hit stock markets around the world. Hosted by Simplecast, an AdsWizz...
30 Apr 202044min
Chasing Wellness: Gilead’s Remdesivir & Tools for Healthy Isolation
A new study from the NIAID revealed that at least 50% of Covid-19 patients treated with a 5-day dosage of Gilead’s Remdesivir reported improved symptoms and were discharged from the hospital within tw...
29 Apr 202026min
